Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2026-05-27 @ 9:14 PM
Study NCT ID:
NCT03468751
Status:
UNKNOWN
Last Update Posted:
2020-06-01
First Post:
2018-03-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors
Sponsor:
Henlix, Inc
Organization: